Mark Lipacis

Feb 05, 2026

ARM received a Outperform rating from Mark Lipacis on Feb 05, 2026, aiming for 170. Momentum has favored the Buy call, with shares climbing from 123.7 to 123.7, rewarding those who trusted the recommendation.

Feb 04, 2026

On Feb 04, 2026, Mark Lipacis published a Outperform outlook on AMD, with a target of 328. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 208.44.

Feb 04, 2026

Mark Lipacis on Feb 04, 2026 assigned TER a Outperform rating, with a price target of 320. The Buy call aligned well with market performance, producing a gain of 11.54%.

Feb 04, 2026

On Feb 04, 2026, Mark Lipacis reaffirmed NXPI with a Outperform rating, targeting 260. Market indecision has kept the 260 target in a holding pattern.

Jan 29, 2026

LRCX was rated Outperform by Mark Lipacis on Jan 29, 2026, with a price objective of 275. This case shows how bullish projections can fail, with the stock now below 231.01.

Dec 03, 2025

Mark Lipacis issued a Outperform recommendation for QBTS on Dec 03, 2025, price target set at 44. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Dec 03, 2025

On Dec 03, 2025, MRVL was evaluated by Mark Lipacis, who gave a Outperform rating and target of 156. Investors saw limited payoff as shares fell short of the 156 target.

Nov 26, 2025

Mark Lipacis rated ADI as Outperform on Nov 26, 2025, setting a price target of 303. The call has proven timely, with shares rising 24.24% toward the price target of 303.

Nov 20, 2025

On Nov 20, 2025, NVDA was given a Outperform rating by Mark Lipacis, with a target price of 352. The stock traded sideways with a 2.64% move, keeping the bullish thesis unresolved.

Nov 13, 2025

GFS received a Outperform rating from Mark Lipacis on Nov 13, 2025, aiming for 45. Momentum has favored the Buy call, with shares climbing from 42.91 to 42.91, rewarding those who trusted the recommendation.

Nov 11, 2025

On Nov 11, 2025, Mark Lipacis published a Outperform outlook on CAMT, with a target of 130. Shares gained 43.15%, underscoring the accuracy of the bullish outlook toward 130.

Nov 07, 2025

Mark Lipacis on Nov 07, 2025 assigned NVMI a Outperform rating, with a price target of 340. The Buy call aligned well with market performance, producing a gain of 49.38%.

Nov 05, 2025

On Nov 05, 2025, Mark Lipacis reaffirmed ONTO with a Outperform rating, targeting 160. The recommendation was supported by strong follow-through as the stock rose from 208.5 to 208.5.

Oct 31, 2025

ALGM was rated Outperform by Mark Lipacis on Oct 31, 2025, with a price objective of 49. A bullish response from the market helped close the gap of 7.43 to the target.

Oct 30, 2025

On Oct 30, 2025, Mark Lipacis initiated coverage on KLAC with a Outperform rating and target of 1350. The stock’s climb of 18.82% since the call highlights the foresight in the rating.

Sep 05, 2025

Mark Lipacis issued a Outperform recommendation for AVGO on Sep 05, 2025, price target set at 370. The target of 370 remains in play, though confirmation will depend on future moves.

Aug 15, 2025

On Aug 15, 2025, AMAT was evaluated by Mark Lipacis, who gave a Outperform rating and target of 209. This case illustrates how a timely bullish rating can translate into tangible gains of 99.38%.

Aug 06, 2025

Mark Lipacis rated ALAB as Outperform on Aug 06, 2025, setting a price target of 215. Shares have remained stable near 169.85, leaving the 215 target still in play.

Mar 04, 2025

On Mar 04, 2025, MCHP was given a Outperform rating by Mark Lipacis, with a target price of 71. The stock rallied 30.74% after the rating, narrowing the gap to the target of 71 and validating the bullish stance.

Aug 20, 2024

TXN received a Outperform rating from Mark Lipacis on Aug 20, 2024, aiming for 268. Momentum has favored the Buy call, with shares climbing from 221.44 to 221.44, rewarding those who trusted the recommendation.